RA may prevent bone metastasis from breast cancer by simultaneously reducing the synthesis of interleukin-8 and the receptor activator of NF kappaB ligand (RANKL/RANK/osteoprotegerin) pathway [266]. Here, CXCL8 is linked to breast cancer.